Why Is ALAMAR BIOSCIENCES I (ALMR) Stock Moving Today?

Why ALMR stock is up today

Alamar Biosciences stock surged 7.56% to $34.43 in the current session driven by a strong intraday rally and positive analyst commentary. The stock opened with a small gap down but quickly reversed course, reaching a session high of $37.76 before settling at $34.43. The volume has already reached 0.8 million shares, more than double the 3-month average. Analysts from Stifel have raised their price target to $32 and maintained a Buy rating, while the CEO has stated the company is well-positioned to sustain upcoming momentum.

What Happened

Alamar Biosciences experienced a sharp intraday rebound after opening at $31.76, a 0.8% decline from the previous day's close. The stock climbed steadily through the morning and hit its high at 12:30 PM ET. The CEO's recent comments about the company's positioning and Stifel's upgraded price target contributed to the optimism. The stock is now trading near its 52-week high of $38.54, with 27 fresh 52-week highs recorded on September 18, 2026. The session has drawn attention as part of broader market movements in the health care sector.

What The Data Shows

The stock's performance is notable given its fundamentals. Alamar Biosciences has a market cap of $2.0 billion and reported a revenue increase of 195.2% in the trailing twelve months. However, the company remains unprofitable with a net margin of -49.5% and an EPS of -2.10. The current session volume of 0.8 million shares is 2.5 times the 3-month average, indicating increased investor interest. The stock is trading within its 52-week range of $18.84 to $38.54.

What To Watch

Investors should monitor the company's upcoming earnings report if one is scheduled. In the absence of a specific date, tracking the breadth of coverage and analyst commentary will provide insight into whether the recent momentum is likely to continue.

Why is ALMR stock moving today?

ALAMAR BIOSCIENCES I (ALMR) is drawing unusual attention today. Our newswire has captured 3 stories on ALMR across 3 sources in the last 36 hours, with AI sentiment reading bullish (avg 60/100). The most recent driver: "Lancet study using Alamar’s technology reveals divergent responses to Alzheimers" (The Fly).

Is ALMR a buy right now?

Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of ALMR coverage reads 60/100 over 3 stories; treat it as a research signal and do your own diligence.

How fast does this page update?

The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.